Korro Bio
Stock Forecast, Prediction & Price Target

Korro Bio Financial Estimates

Korro Bio Revenue Estimates

Korro Bio EBITDA Estimates

Korro Bio Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$14.06M
 
N/A
$0
 
-100%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Net Income
 
% change YoY
$-21.95M
 
N/A
$-58.03M
 
-164.27%
$-81.17M
 
-39.87%
Avg: $-92.65M
Low: $-16.91M
High: $-10.47M
avg. -14.14%
Avg: $-101.84M
Low: $-15.59M
High: $-9.63M
avg. -9.92%
Avg: $-12.74M
Low: $-12.74M
High: $-12.74M
avg. 87.48%
Avg: $-12.86M
Low: $-12.86M
High: $-12.86M
avg. -0.95%
EBITDA
 
% change YoY
$-33.89M
 
N/A
$-56.48M
 
-66.63%
$-80.90M
 
-43.22%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$4.94
 
N/A
-$227.58
 
-4506.88%
-$53.09
 
76.67%
Avg: -$9.44
Low: -$11.06
High: -$6.85
avg. 82.22%
Avg: -$8.25
Low: -$10.2
High: -$6.3
avg. 12.57%
Avg: -$8.34
Low: -$8.34
High: -$8.34
avg. -1.03%
Avg: -$8.42
Low: -$8.42
High: -$8.42
avg. -0.95%
Operating Expenses
 
% change YoY
$35.49M
 
N/A
$58.99M
 
66.21%
$84.53M
 
43.28%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Korro Bio stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 15.61% in 2025-2028.

We have gathered data from 2 analysts. Their low estimate is -16.91M, average is -92.65M and high is -10.47M.

What is Korro Bio stock revenue growth forecast?

We have gathered data from 4 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Korro Bio stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 23.20% in 2025-2028.

We have gathered data from 2 analysts. Their low earnings per share estimate is -$11.06, average is -$9.44 and high is $-6.85.

What is the best performing analyst?

In the last twelve months analysts have been covering Korro Bio stock. The most successful analyst is Luca Issi.